Thus, we suggest that patients whose complex aphthosis does not respond to colchicine in their initial therapeutic trial continue taking colchicine when dapsone is added to the regimen.
因此,我么你建议,在开始接受碱治疗效果不明显转而接受氨苯砜治疗的
当继
服用
碱。
Thus, we suggest that patients whose complex aphthosis does not respond to colchicine in their initial therapeutic trial continue taking colchicine when dapsone is added to the regimen.
因此,我么你建议,在开始接受碱治疗效果不明显转而接受氨苯砜治疗的
当继
服用
碱。
声明:以上例句、词性分类均由互联网资源自动生成,部分未经过人工审核,其表达内容亦不代表本软件的观点;若发现问题,欢迎向我们指正。
Thus, we suggest that patients whose complex aphthosis does not respond to colchicine in their initial therapeutic trial continue taking colchicine when dapsone is added to the regimen.
因此,我么你建议,在开始接受秋水治
效果不明显转而接受氨苯砜治
者应当继
服用秋水
。
明:以上例句、词性分类均由互联网资源自动生成,部分未经过人工审核,其表达内容亦不代表本软件
观点;若发现问题,欢迎向我们指正。
Thus, we suggest that patients whose complex aphthosis does not respond to colchicine in their initial therapeutic trial continue taking colchicine when dapsone is added to the regimen.
因此,我么你建议,在开始接受秋水仙碱治疗效果不而接受氨苯砜治疗的患者应当继
服用秋水仙碱。
声:以上例句、词性
由互联网资源自动生成,部
未经过人工审核,其表达内容亦不代表本软件的观点;若发现问题,欢迎向我们指正。
Thus, we suggest that patients whose complex aphthosis does not respond to colchicine in their initial therapeutic trial continue taking colchicine when dapsone is added to the regimen.
因此,我么你建议,在开始接受秋水仙碱治疗效显转而接受氨苯砜治疗的患者应当继
服用秋水仙碱。
声:以上例句、词性分类
联网资源自动生成,部分未经过人工审核,其表达内容亦
代表本软件的观点;若发现问题,欢迎向我们指正。
Thus, we suggest that patients whose complex aphthosis does not respond to colchicine in their initial therapeutic trial continue taking colchicine when dapsone is added to the regimen.
因此,我么你建议,在开始接受秋水仙碱治疗效果明显转而接受氨苯砜治疗的患者应当继
服用秋水仙碱。
声明:以上例句、词性分类均由互联网资源自动生成,部分未经过人工审核,其达内容亦
本软件的观点;若发现问题,欢迎向我们指正。
Thus, we suggest that patients whose complex aphthosis does not respond to colchicine in their initial therapeutic trial continue taking colchicine when dapsone is added to the regimen.
因此,我么你建议,在开始接受秋水仙效果不
显转而接受氨苯砜
患者应当继
服用秋水仙
。
:以上例句、词性分类均由互联网资源自动生成,部分未经过人工审核,其表达内容亦不代表本软件
观点;若发现问题,欢迎向我们指正。
Thus, we suggest that patients whose complex aphthosis does not respond to colchicine in their initial therapeutic trial continue taking colchicine when dapsone is added to the regimen.
因此,我么你建议,在开始接受秋治疗效果不明显转而接受氨苯砜治疗的患者应当继
服用秋
。
声明:以上例句、词性分类均由互联网资生成,部分未经过人工审核,其表达内容亦不代表本软件的观点;若发现问题,欢迎向我们指正。
Thus, we suggest that patients whose complex aphthosis does not respond to colchicine in their initial therapeutic trial continue taking colchicine when dapsone is added to the regimen.
,
么你建议,在开始接受秋水仙碱治疗效果不明显转而接受氨苯砜治疗的患者应当继
服用秋水仙碱。
声明:以上例句、词性分类均由互联网资源自动生成,部分未经过人工审,
达内容亦不代
本软件的观点;若发现问题,欢迎向
们指正。
Thus, we suggest that patients whose complex aphthosis does not respond to colchicine in their initial therapeutic trial continue taking colchicine when dapsone is added to the regimen.
因此,我么你建议,在开始秋水仙碱治疗效果不明显转而
苯砜治疗的患者应当继
服用秋水仙碱。
声明:以上、词性分类均由互联网资源自动生成,部分未经过人工审核,其表达内容亦不代表本软件的观点;若发现问题,欢迎向我们指正。